Companies Dominating the Epinephrine Landscape
- Teva Pharmaceuticals Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amneal Pharmaceuticals, Inc.
- Adamis Pharmaceuticals Corporation
- Antares Pharma, Inc.
- Pfizer Inc.
- kaleo, Inc.
- ALK-Abelló A/S
- Bausch Health Companies Inc.
- Viatris Inc.
- Abbott Laboratories
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Epinephrine Market in 2025 is estimated at USD 1.38 billion.
The global market size was around USD 1.25 billion in 2024 and is likely to expand at a CAGR of more than 12.5%, surpassing USD 5.78 billion revenue by 2037.
North America is expected to exceed majority share by 2037, attributed to escalating count of patients suffering from respiratory diseases such as asthma, coupled with the rapidly expanding population in the region.
The major players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
